The Application of Donepezil in the treatment of Alzheimer's disease

Donepezil was first approved to be prescribed in 1996, mainly to delay the progressive worsening of cognitive symptomatology of patients diagnosed with Alzheimer's Disease. Learn more: donepezil.
Alzheimer's disease (AD) is a neurodegenerative disease that usually starts slowly and progressively worsens. AD is the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that affects a person's ability to function independently.